Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Structure–Function Relationships in Glaucoma: A Comparison of Different Functional Tests

C.A. Johnson; S.K. Gardiner; G.A. Cioffi

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1123.

ARVO Annual Meeting Abstract May 2006

Comparison Between Multifocal Visual Evoked Potentials (mfVEP) and Standard Automated Perimetry (SAP) in High–Risk Ocular Hypertension and Early Glaucoma

B. Fortune; S. Demirel; X. Zhang; D.C. Hood; E. Patterson; A. Jamil; S.L. Mansberger; G.A. Cioffi; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1126.

ARVO Annual Meeting Abstract May 2006

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS) and the Optic Neuritis Treatment Trial (ONTT)

J.L. Keltner; C.A. Johnson; K.E. Cello; J. Fan; R.A. Levine; S.E. Bandermann; M.A. Kass; M.O. Gordon; R.W. Beck; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3394.

ARVO Annual Meeting Abstract May 2006

Why Does The Prevalence Of Progression Appear To Be Low In Early Glaucoma? Practice Effects In Clinical Trials

S.K. Gardiner; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3397.

ARVO Annual Meeting Abstract May 2006

Screening Tests for Visually Significant Eye Diseases in American Indian/Alaska Native Participants

S.L. Mansberger; G.A. Cioffi; D. Choi; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3472.

ARVO Annual Meeting Abstract May 2006

Distinguishing Between Normal and Early Glaucomatous Eyes Using Pulsar Perimetry

G. Migliorati; M. Zeppieri; M.L. Salvetat; P. Brusini; C. Tosoni; L. Parisi; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3991.

ARVO Annual Meeting Abstract May 2005

Comparison of Corneal Thickness Between Dogs With Retinal Dystrophy Due to a Null Mutation in Cyclic GMP Phosphodiesterase Alpha (PDE6A) and Phenotypically Normal Heterozygous Carriers

D.M. Eifler; F.M. Montiani–Ferreria; F.F. Cardoso; C.A. Johnson; S.M. Petersen–Jones

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2180.

ARVO Annual Meeting Abstract May 2005

The Influence of Instruction on Frequency Doubling Technology Perimetry and Humphrey Matrix Results in Normals and Early Glaucoma Patients

G. Takahashi; Y. Aoki; T. Koike; T. Nakano; K. Kitahara; S. Demirel; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2482.

ARVO Annual Meeting Abstract May 2005

Mapping the Sectors of the Neuroretinal Rim (HRT) to the Visual Field in Glaucoma

S.K. Gardiner; C.A. Johnson; G.A. Cioffi; C. Blachly

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):2539.

ARVO Annual Meeting Abstract May 2005

Visual Field Quality Control in the Ocular Hypertension Treatment Study (OHTS): and in the 10–Year Optic Neuritis Treatment Trial (ONTT) Follow–Up Study

J.L. Keltner; C.A. Johnson; K.E. Cello; J. Fan; S.E. Bandermann; M.A. Kass; M.O. Gordon; R.W. Beck; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3738.

ARVO Annual Meeting Abstract May 2005

The Influence of Optical Media Opacities on Humphrey Matrix Frequency Doubling Technology (FDT) Perimetry Results

C.A. Johnson; K. Kent; S. Demirel

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3740.

ARVO Annual Meeting Abstract May 2005

Utilizing Higher Order Kernels to Improve the Signal–to–Noise Ratio of the Multifocal Visual Potential (mfVEP)

X. Zhang; B. Fortune; D.C. Hood; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3759.

ARVO Annual Meeting Abstract May 2005

Normal Pediatric Thresholds Using Frequency Doubling Technology Perimetry

L.M. Quinn; D.T. Wheeler; S.K. Gardiner; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4662.

ARVO Annual Meeting Abstract May 2005

Measurement of Visual Acuity With Lea Symbols and Lea Numbers: Comparison to Adult Standards

C.A. Johnson; S. Lyons; N. Quinn; J. Hartzell; T. Travison; M. Suckow; S. Huffer; M. Ioussifova; B. Moore

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):1934.

ARVO Annual Meeting Abstract May 2004

Chick Eyes Show A Diurnal Rhythm In Refractive Error

C.A. Johnson; G. Lytle; D. Troilo; D.L. Nickla

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):4295.

ARVO Annual Meeting Abstract May 2004

Types of Visual Field Abnormalities that Subsequently Become Visual Field Primary Open–Angle Glaucoma in the Ocular Hypertension Treatment Study (OHTS)

J.L. Keltner; C.A. Johnson; J. Fan; K.E. Cello; M.A. Kass; M.O. Gordon; Ocular Hypertension Treatment Study Group

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2134.

ARVO Annual Meeting Abstract May 2004

Investigation of racial differences in responsiveness to frequency doubling technology (FDT) perimetry in normal subjects

T. Nakano; G. Takahashi; S. Demirel; K. Kitahara; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):2136.

ARVO Annual Meeting Abstract May 2004

Detection of Glaucomatous Visual Field Loss Using the Humphrey Matrix Frequency Doubling Technology (FDT) Perimeter

C.A. Johnson; S. Demirel; A.J. Anderson; B.C. Chauhan; M. Fingeret; P.G. D. Spry

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):3470.

ARVO Annual Meeting Abstract May 2003

Predicting Glaucomatous Visual Field Loss Using Short Wavelength Automated Perimetry

G. Takahashi; S. Demirel; C.A. Johnson

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):59.

ARVO Annual Meeting Abstract May 2003

Normal Aging Effects for Two Forms of Frequency Doubling Technology (fdt) Perimetry Using a 24-2 Stimulus Presentation Pattern

C.A. Johnson; A.J. Anderson; P.G. Spry; M. Fingeret; J.L. Keltner; K. Schindler; M. Wall; J.S. Werner

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):64.

1 2

Next 20 Results »

Advertisement